Boon, Wouter; Martins, Luis; Koopmanschap, Marc - In: Health Policy 119 (2015) 2, pp. 180-185
When entering the market, orphan drugs are associated with substantial prices and a high degree of uncertainty … orphan drugs. We find that the conditional reimbursement scheme is the result of years of discussion and returning public … reimbursement of orphan drugs in the Netherlands. …